MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.xcrm.2022.100535

Медицинская библиотека · Cell reports. Medicine · 2022

Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern.

Kitchin Dale, Richardson Simone I, van der Mescht Mieke A, Motlou Thopisang, Mzindle Nonkululeko, Moyo-Gwete Thandeka, Makhado Zanele, Ayres Frances, Manamela Nelia P, Spencer Holly, Lambson Bronwen, Oosthuysen Brent, Kaldine Haajira, du Pisanie Marizane, Mennen Mathilda, Skelem Sango, Williams Noleen, Ntusi Ntobeko A B, Burgers Wendy A, Gray Glenda G, Bekker Linda-Gail, Boswell Michael T, Rossouw Theresa M, Ueckermann Veronica, Moore Penny L

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

The Janssen (Johnson & Johnson) Ad26.COV2.S non-replicating viral vector vaccine has been widely deployed for COVID-19 vaccination programs in resource-limited settings. Here we confirm that neutralizing and binding antibody responses to Ad26.COV2.S vaccination are stable for 6 months post-vaccination, when tested against multiple SARS-CoV-2 variants. Secondly, using longitudinal samples from individuals who experienced clinically mild breakthrough infections 4 to 5 months after vaccination, we show dramatically boosted binding antibodies, Fc effector function, and neutralization. These high titer responses are of similar magnitude to humoral immune responses measured in convalescent donors who had been hospitalized with severe illness, and are cross-reactive against diverse SARS-CoV-2 variants, including the neutralization-resistant Omicron (B.1.1.529) variant that currently dominates global infections, as well as SARS-CoV-1. These data have implications for population immunity in areas where the Ad26.COV2.S vaccine has been widely deployed, but where ongoing infections continue to occur at high levels.

Для цитирования: Kitchin Dale, Richardson Simone I, van der Mescht Mieke A, Motlou Thopisang, Mzindle Nonkululeko, Moyo-Gwete Thandeka, Makhado Zanele, Ayres Frances, Manamela Nelia P, Spencer Holly, Lambson Bronwen, Oosthuysen Brent, Kaldine Haajira, du Pisanie Marizane, Mennen Mathilda, Skelem Sango, Williams Noleen, Ntusi Ntobeko A B, Burgers Wendy A, Gray Glenda G, Bekker Linda-Gail, Boswell Michael T, Rossouw Theresa M, Ueckermann Veronica, Moore Penny L. Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern.. Cell reports. Medicine. 2022. DOI: 10.1016/j.xcrm.2022.100535.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.